Reported 3 days ago
Tempus AI, a healthcare-focused AI company, saw its stock price plummet 13.2% this week after a critical report from Spruce Point Capital Management questioned the company's financial integrity and partnership claims. While investors should approach Tempus AI with caution, some notable figures, like Cathie Wood from Ark Invest, are still showing support for the stock. Potential investors are advised to monitor the company's responses to the concerns raised.
Source: YAHOO